Literature DB >> 8746294

Environmental tobacco smoke.

M R Law1, A K Hackshaw.   

Abstract

Environmental tobacco smoke is an important contaminant of indoor air. For a non-smoker living with a smoker the exposure is equivalent to about 1% of that from actively smoking 20 cigarettes a day (based on plasma cotinine). There is strong and consistent evidence that passive smoking increases the risk of lung cancer. It is estimated that there is an increase in risk of 24% (95% confidence interval 11-38%) compared to unexposed non-smokers, and several hundred lung cancer deaths per year in Britain are attributable to environmental tobacco smoke exposure. Passive smoking is associated with an increase in risk of chronic respiratory disease in adults of 25% (10-43%), and increases the risk of acute respiratory illness in children, by 50-100%. It is likely that passive smoking increases the risk of ischaemic heart disease, and that exposure in pregnancy lowers birthweight, but there is inconsistency between different estimates of the magnitude of risk. The overall hazard is sufficient to justify measures to restrict smoking in public places and workplaces, and to discourage people from smoking in their homes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8746294     DOI: 10.1093/oxfordjournals.bmb.a011528

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  25 in total

Review 1.  The cost to society of smoking cessation.

Authors:  D Cohen; G Barton
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

2.  Characteristics of women exposed and unexposed to environmental tobacco smoke (ETS) in a general population sample of North Italy (Po River Delta epidemiological study).

Authors:  M Simoni; L Carrozzi; S Baldacci; M Pedreschi; F Di Pede; A Angino; F Pistelli; G Viegi
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Environmental tobacco smoke and laryngeal cancer: results from a population-based case-control study.

Authors:  Heribert Ramroth; Andreas Dietz; Heiko Becher
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-01       Impact factor: 2.503

4.  Passive smoking and health: should we believe Philip Morris's "experts"?

Authors:  G D Smith; A N Phillips
Journal:  BMJ       Date:  1996-10-12

5.  CYP2A6 deletion polymorphism is associated with decreased susceptibility of lung cancer in Asian smokers: a meta-analysis.

Authors:  Yu-liang Liu; Yu Xu; Fan Li; Hong Chen; Shu-liang Guo
Journal:  Tumour Biol       Date:  2013-05-07

6.  Estimate of deaths attributable to passive smoking among UK adults: database analysis.

Authors:  Konrad Jamrozik
Journal:  BMJ       Date:  2005-03-01

7.  Association of environmental tobacco smoke exposure with socioeconomic status in a population of 7725 New Zealanders.

Authors:  G Whitlock; S MacMahon; S Vander Hoorn; P Davis; R Jackson; R Norton
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

8.  A review of interventions for reduction of residential environmental tobacco smoke exposures among children.

Authors:  C E Adair; S Patten
Journal:  Paediatr Child Health       Date:  2001-02       Impact factor: 2.253

9.  Investigation of heavy metal content of Turkish tobacco leaves, cigarette butt, ash, and smoke.

Authors:  Füsun Okçu Pelit; Ruken Esra Demirdöğen; Emür Henden
Journal:  Environ Monit Assess       Date:  2013-05-28       Impact factor: 2.513

Review 10.  Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).

Authors:  Bertrand Dautzenberg; Mitchell Nides; Jean-Luc Kienzler; Anne Callens
Journal:  BMC Clin Pharmacol       Date:  2007-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.